CDK4 and lung carcinoma: Earlier data from our laboratory has shown that P276-00, a Cdk inhibitor inhibits cyclin D1 and down regulates Cdk4 specific phosphorylation of RB at Ser780 (pRbSer780) along with up regulation of p27 and p21 in breast and lung cancer cell lines [20,21].